Additional Information

Description

Buprenorphine 2 mg Sublingual tablets are a critical formulation used primarily for the induction and initial titration phases of medication-assisted treatment for opioid use disorder, allowing for precise dosing adjustments as patients transition onto therapy. Supplied in a 5x10 pack (50 tablets total), this packaging supports the frequent dosing adjustments required in early treatment. Like the higher strengths, this 2mg uncoated tablet is administered sublingually once daily and must be fully dissolved under the tongue to ensure proper absorption and bioavailability. It carries the same boxed warnings concerning the risk of addiction, life-threatening precipitated withdrawal if administered before the onset of moderate opioid withdrawal, and the critical danger of accidental pediatric ingestion, mandating secure storage and dispensation with appropriate patient counseling.